December 14, 2017
Atsushi Kamide, Vice President, Healthcare Policy & CSR, Astellas Pharma The government’s modified proposal on the so-called price maintenance premium (PMP) reflects some of the requests being made by the pharmaceutical industry, but continued discussions should be held to further...read more